Discovery of immunosuppressant tacrolimus (Tac, FK506)

被引：0
|
作者：
Goto, T [1 ]
机构：
[1] Fujisawa Pharmaceut Co Ltd, Res, Osaka 5328514, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2005年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：35P / 35P
页数：1
相关论文
共 50 条
  • [21] Oral ulcerations associated with the administration of Tacrolimus (FK506)
    Hernandez, G
    Jimenez, C
    Arriba, L
    Gonzalez, V
    Moreno, E
    JOURNAL OF DENTAL RESEARCH, 2001, 80 (04) : 1302 - 1302
  • [22] Effect of FK506 (tacrolimus) in animal models of inflammation
    Amanpreet Singh
    Pattipati S. Naidu
    C. S. Patil
    Shrinivas K. Kulkarni
    InflammoPharmacology, 2003, 11 (3) : 249 - 257
  • [23] Interactions of FK506 (tacrolimus) with clinically important drugs
    Matsuda, H
    Iwasaki, K
    Shiraga, T
    Tozuka, Z
    Hata, T
    Guengerich, FP
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1996, 91 (01) : 57 - 64
  • [24] The immunosuppressant FK506 ameliorates ischaemic damage in the rat brain
    Drake, M
    Friberg, H
    BorisMoller, F
    Sakata, K
    Wieloch, T
    ACTA PHYSIOLOGICA SCANDINAVICA, 1996, 158 (02): : 155 - 159
  • [25] Regulation of bone metabolism in immunosuppressant (FK506)-treated rats
    Shiho Kirino
    Jyoji Fukunaga
    Shuji Ikegami
    Hiroshi Tsuboi
    Masataka Kimata
    Naoki Nakata
    Makoto Nakano
    Takaaki Ueno
    Nobuyoshi Mizukawa
    Toshio Sugahara
    Journal of Bone and Mineral Metabolism, 2004, 22 : 554 - 560
  • [26] STRUCTURE OF FK506 - A NOVEL IMMUNOSUPPRESSANT ISOLATED FROM STREPTOMYCES
    TANAKA, H
    KURODA, A
    MARUSAWA, H
    HATANAKA, H
    KINO, T
    GOTO, T
    HASHIMOTO, M
    TAGA, T
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (16) : 5031 - 5033
  • [27] Tacrolimus (FK506) malabsorption: Management with fluconazole coadministration
    Dhawan, A
    Tredger, JM
    NorthLewis, PJ
    Gonde, CE
    Mowat, AP
    Heaton, NJ
    TRANSPLANT INTERNATIONAL, 1997, 10 (04) : 331 - 334
  • [28] Effect of tacrolimus (FK506) in experimental glomerulonephritis model
    Neijmann, S. Tekin
    Ozkan, N.
    Taga, Y.
    Cakaloglu, F.
    FEBS JOURNAL, 2007, 274 : 294 - 294
  • [29] Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet
    Starzl, TE
    Todo, S
    Demetris, AJ
    Fung, JJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (06) : S7 - S14
  • [30] FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506
    Xu, XH
    Su, B
    Barndt, RJ
    Chen, HY
    Xin, HB
    Yan, GF
    Chen, LY
    Cheng, DS
    Heitman, J
    Zhuang, Y
    Fleischer, S
    Shou, WN
    TRANSPLANTATION, 2002, 73 (11) : 1835 - 1838
12345